Published in Acta Otolaryngol on January 01, 1982
Increased signal intensity of the cochlea on pre- and post-contrast enhanced 3D-FLAIR in patients with vestibular schwannoma. Neuroradiology (2009) 0.84
The relationship between pure tone thresholds and the radiological dimensions of acoustic neuromas. Skull Base Surg (1998) 0.75
Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet (1992) 3.55
Central nervous system sarcoidosis--diagnosis and management. QJM (1999) 3.11
Experiences with a translabyrinthine-transtentorial approach to the cerebellopontine angle. Technical note. J Neurosurg (1973) 2.15
Emergency treatment of tracheal tear during pharyngolaryngectomy. Ann R Coll Surg Engl (1992) 2.03
Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry (1996) 2.02
Chronic subdural haematoma. Q J Med (1979) 1.81
Underenumeration in the 1991 census. BMJ (1993) 1.71
Elevated serum levels of tumor necrosis factor-alpha in Guillain-Barré syndrome. Ann Neurol (1993) 1.71
Adaptation of the nitrate reductase and Griess reaction methods for the measurement of serum nitrate plus nitrite levels. Ann Clin Biochem (1997) 1.63
Fatigue is not associated with raised inflammatory markers in multiple sclerosis. Neurology (2001) 1.58
Community-based infant hearing screening for early detection of permanent hearing loss in Lagos, Nigeria: a cross-sectional study. Bull World Health Organ (2008) 1.55
Radiological malformations of the ear in Pendred syndrome. Clin Radiol (1998) 1.52
Genetic factors in otosclerosis. Ann R Coll Surg Engl (1967) 1.47
Pendred syndrome--100 years of underascertainment? QJM (1997) 1.45
Psychiatric morbidity in patients with peripheral vestibular disorder: a clinical and neuro-otological study. J Neurol Neurosurg Psychiatry (1992) 1.45
Isoelectric focusing versus quantitative measurements in the detection of intrathecal local synthesis of IgG. Clin Chim Acta (1990) 1.45
Oligoclonal immunoglobulins and plasma cells in spinal fluid of patients with multiple sclerosis. Br Med J (1979) 1.41
Inactivation of metronidazole by aerobic organisms. J Antimicrob Chemother (1979) 1.41
Infant hearing screening: route to informed choice. Arch Dis Child (2004) 1.41
Lack of serum oligoclonal antibody responses to Chlamydophila pneumoniae in multiple sclerosis. Eur Neurol (2005) 1.38
Anti-basal ganglia antibodies in acute and persistent Sydenham's chorea. Neurology (2002) 1.38
Some Studies on the Rh Factor and its Significance in Obstetrical Practice. Can Med Assoc J (1944) 1.34
A quantitative technique for growing human adult skeletal muscle in culture starting from mononucleated cells. J Neurol Sci (1977) 1.32
Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry (2001) 1.30
Seven years' experience with antilymphoblast globulin for renal transplantation from cadaver donors. Ann Surg (1976) 1.26
Markers for gene expression in cultured cells from the nervous system. J Biol Chem (1972) 1.26
Autophony and the patulous eustachian tube. Laryngoscope (1981) 1.25
Translabyrinthine and transtentorial removal of acoustic nerve tumors. Results in 150 cases. J Neurosurg (1980) 1.25
Bilateral loss of vestibular function: clinical findings in 53 patients. J Neurol (1998) 1.25
A specific ELISA for measuring neurofilament heavy chain phosphoforms. J Immunol Methods (2003) 1.24
Blood-brain barrier damage in patients with bacterial meningitis: association with tumor necrosis factor-alpha but not interleukin-1 beta. J Infect Dis (1992) 1.20
The predictive value of intrathecal immunoglobulin synthesis and magnetic resonance imaging in acute isolated syndromes for subsequent development of multiple sclerosis. Ann Neurol (1991) 1.20
A rapid method for detecting oligoclonal IgG in unconcentrated CSF, by agarose isoelectric focusing, transfer to cellulose nitrate and immunoperoxidase staining. J Neuroimmunol (1983) 1.19
Increased tau in the cerebrospinal fluid of patients with frontotemporal dementia and Alzheimer's disease. Neurosci Lett (1999) 1.17
Herpes simplex encephalitis: an audit of the use of laboratory diagnostic tests. QJM (2004) 1.15
Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations. Brain (2002) 1.13
Benefits and challenges of newborn hearing screening for developing countries. Int J Pediatr Otorhinolaryngol (2004) 1.13
Tinnitus: its causes, diagnosis, and treatment. BMJ (1993) 1.11
Anti-myelin antibodies do not allow earlier diagnosis of multiple sclerosis. Mult Scler (2005) 1.11
Double-blind controlled trial of immunosuppression in the treatment of multiple sclerosis: final report. Lancet (1982) 1.09
The inheritance of otosclerosis. J Laryngol Otol (1970) 1.08
Isoelectric focusing of cerebrospinal fluid immunoglobulin G: an annotated update. Ann Clin Biochem (1990) 1.08
Axonal damage and outcome in subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry (2006) 1.08
Cerebrospinal fluid ferritin in brain necrosis: evidence for local synthesis. Clin Chim Acta (1993) 1.07
Daily urinary neopterin excretion as an immunological marker of disease activity in multiple sclerosis. Brain (1997) 1.07
New ultramicromethod for concentration of cerebrospinal fluid. Lancet (1976) 1.07
An ELISA for glial fibrillary acidic protein. J Immunol Methods (2004) 1.07
Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up study. J Neurol Neurosurg Psychiatry (2005) 1.07
Poststreptococcal acute disseminated encephalomyelitis with basal ganglia involvement and auto-reactive antibasal ganglia antibodies. Ann Neurol (2001) 1.06
Double-blind, controlled trial of immunosuppression in treatment of multiple sclerosis. Lancet (1980) 1.06
Laboratory diagnosis of multiple sclerosis: immunological and biochemical aspects. Br Med Bull (1977) 1.06
Lipid studies in the blood and brain in multiple sclerosis and motor neurone disease. J Clin Pathol (1965) 1.05
Antigen-dependent intrathecal antibody synthesis in the normal rat brain: tissue entry and local retention of antigen-specific B cells. J Immunol (1998) 1.05
Oligoclonal banding of IgG in CSF, blood-brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Behçet's disease involving the nervous system. J Neurol Neurosurg Psychiatry (1995) 1.04
Facial nerve preservation in relation to tumour size in acoustic nerve tumour surgery. J Laryngol Otol (1973) 1.04
Steroid treatment in congenital syphilitic deafness. J Laryngol Otol (1968) 1.04
A longitudinal study of symptoms, anxiety and subjective well-being in patients with vertigo. Clin Otolaryngol Allied Sci (1994) 1.04
Clinical experience with the Vibrant Soundbridge implant device. Otol Neurotol (2001) 1.03
Evidence for increased nitric oxide production in multiple sclerosis. J Neurol Neurosurg Psychiatry (1995) 1.03
CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis. Neurology (2004) 1.03
Relationship between balance system function and agoraphobic avoidance. Behav Res Ther (1995) 1.03
A study of oligoclonal band negative multiple sclerosis. J Neurol Neurosurg Psychiatry (1996) 1.02
Free light chains in the cerebrospinal fluid: an indicator of recent immunological stimulation. J Neurol Neurosurg Psychiatry (1985) 1.02
In vivo relationship of tumor necrosis factor-alpha to blood-brain barrier damage in patients with active multiple sclerosis. J Neuroimmunol (1992) 1.02
Cerebrospinal fluid tau concentrations in HIV infected patients with suspected neurological disease. Sex Transm Infect (2000) 1.01
Antibody synthesis within the central nervous system: comparisons of CSF IgG indices and electrophoresis. J Clin Pathol (1983) 1.00
Bilateral loss of vestibular function. Acta Otolaryngol Suppl (1995) 1.00
A specific and sensitive ELISA for measuring S-100b in cerebrospinal fluid. J Immunol Methods (1997) 0.99
Dizziness following head injury: a neuro-otological study. J Neurol (1995) 0.99
Cerebrospinal fluid S100B correlates with brain atrophy in Alzheimer's disease. Neurosci Lett (2003) 0.99
Management of severe deafness in adults. The otologist's contribution. Proc R Soc Med (1969) 0.99
Hormones and the auditory system: a review of physiology and pathophysiology. Neuroscience (2008) 0.98
Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-alpha and blood-brain barrier damage. J Neuroimmunol (1993) 0.98
Serum inflammatory markers and clinical/MRI markers of disease progression in multiple sclerosis. J Neurol (2001) 0.98
Aetiology and clinical presentations of auditory processing disorders--a review. Arch Dis Child (2001) 0.97
Cerebrospinal fluid (CSF) and serum S100B: release and wash-out pattern. Brain Res Bull (2003) 0.97
Progressive auditory neuropathy in patients with Leber's hereditary optic neuropathy. J Neurol Neurosurg Psychiatry (2004) 0.97
Quantification of neurodegeneration by measurement of brain-specific proteins. J Neuroimmunol (2003) 0.97
Bilateral cerebellopontine angle tumors in neurofibromatosis type 2. J Neurosurg (1991) 0.97
Treatment response in relation to inflammatory and axonal surrogate marker in multiple sclerosis. Mult Scler (2004) 0.97
Multiple sclerosis: Neurofilament light chain antibodies are correlated to cerebral atrophy. Neurology (2003) 0.97
'Silence in court': twenty-one years of otolaryngology litigation. J Laryngol Otol (1990) 0.96
On the role of glial cells in the mammalian nervous system. Uptake, excretion, and metabolism of putative neurotransmitters by cultured glial tumor cells. J Biol Chem (1974) 0.96
The potential role of nitric oxide in multiple sclerosis. Mult Scler (1998) 0.96
Auditory temporal processing deficits in patients with insular stroke. Neurology (2006) 0.96
Mechanisms of hearing loss in acoustic neuroma: an otoacoustic emission study. Acta Otolaryngol (1995) 0.96
Translabyrinthine surgical approach to the internal acoustic meatus. J R Soc Med (1978) 0.96
The neck-eye reflex in patients with reduced vestibular and optokinetic function. Brain (1991) 0.95
Primary facial nerve tumors within the skull. J Neurosurg (1990) 0.95
Age-related changes in cerebrospinal fluid protein concentrations. J Neurol Sci (1991) 0.95
Subarachnoid hemorrhage and papilledema due to a cervical neurilemmoma. Case report. J Neurosurg (1978) 0.94
"A bit dizzy". Br J Hosp Med (1984) 0.94
A micro-method for measuring total protein in cerebrospinal fluid by using benzethonium chloride in microtiter plate wells. Clin Chem (1989) 0.94
The spectrum of antineuronal autoantibodies in a series of neurological patients. J Neurol Sci (2004) 0.93
Affinity distributions of antigen-specific IgG in patients with multiple sclerosis and in patients with viral encephalitis. J Immunol Methods (1990) 0.93
Detection of 14-3-3 brain protein in cerebrospinal fluid of HIV infected patients. Sex Transm Infect (2000) 0.93
Controlled study of 24-hour ambulatory electrocardiographic monitoring in patients with transient neurological symptoms. J Neurol Neurosurg Psychiatry (1980) 0.93
Acute axonal damage predicts clinical outcome in patients with multiple sclerosis. Mult Scler (2005) 0.92